Clinical Trial Update: Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing aliskiren added to losartan versus losartan alone evaluated regression of left ventricular hypertrophy in overweight adults with essen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Left Ventricular Hypertrophy

Drugs mentioned

• Cozaar (losartan)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension, Left Ventricular Hypertrophy | Phase 3 | Status: COMPLETED | Results posted: 2011-05-10